Proliferative Diabetic Retinopathy Market
1 Study Coverage
1.1 Proliferative Diabetic Retinopathy Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million) Introduction
1.2 Global Proliferative Diabetic Retinopathy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Proliferative Diabetic Retinopathy Market Size for the Year 2017-2028
1.2.2 Global Proliferative Diabetic Retinopathy Market Size for the Year 2017-2028
1.3 Proliferative Diabetic Retinopathy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Proliferative Diabetic Retinopathy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Proliferative Diabetic Retinopathy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Proliferative Diabetic Retinopathy Market Dynamics
1.4.1 Proliferative Diabetic Retinopathy Industry Trends
1.4.2 Proliferative Diabetic Retinopathy Market Drivers
1.4.3 Proliferative Diabetic Retinopathy Market Challenges
1.4.4 Proliferative Diabetic Retinopathy Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Proliferative Diabetic Retinopathy by Type
2.1 Proliferative Diabetic Retinopathy Market Segment by Type
2.1.1 Anti-VEGF Agents
2.1.2 Corticosteroids
2.2 Global Proliferative Diabetic Retinopathy Market Size by Type (2017, 2022 & 2028)
2.3 Global Proliferative Diabetic Retinopathy Market Size by Type (2017-2028)
2.4 United States Proliferative Diabetic Retinopathy Market Size by Type (2017, 2022 & 2028)
2.5 United States Proliferative Diabetic Retinopathy Market Size by Type (2017-2028)
3 Proliferative Diabetic Retinopathy by Application
3.1 Proliferative Diabetic Retinopathy Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Proliferative Diabetic Retinopathy Market Size by Application (2017, 2022 & 2028)
3.3 Global Proliferative Diabetic Retinopathy Market Size by Application (2017-2028)
3.4 United States Proliferative Diabetic Retinopathy Market Size by Application (2017, 2022 & 2028)
3.5 United States Proliferative Diabetic Retinopathy Market Size by Application (2017-2028)
4 Global Proliferative Diabetic Retinopathy Competitor Landscape by Company
4.1 Global Proliferative Diabetic Retinopathy Market Size by Company
4.1.1 Top Global Proliferative Diabetic Retinopathy Companies Ranked by Revenue (2021)
4.1.2 Global Proliferative Diabetic Retinopathy Revenue by Player (2017-2022)
4.2 Global Proliferative Diabetic Retinopathy Concentration Ratio (CR)
4.2.1 Proliferative Diabetic Retinopathy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Proliferative Diabetic Retinopathy in 2021
4.2.3 Global Proliferative Diabetic Retinopathy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Proliferative Diabetic Retinopathy Headquarters, Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million) Type
4.3.1 Global Proliferative Diabetic Retinopathy Headquarters and Area Served
4.3.2 Global Proliferative Diabetic Retinopathy Companies Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Proliferative Diabetic Retinopathy Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Proliferative Diabetic Retinopathy Market Size by Company
4.5.1 Top Proliferative Diabetic Retinopathy Players in United States, Ranked by Revenue (2021)
4.5.2 United States Proliferative Diabetic Retinopathy Revenue by Players (2020, 2021 & 2022)
5 Global Proliferative Diabetic Retinopathy Market Size by Region
5.1 Global Proliferative Diabetic Retinopathy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Proliferative Diabetic Retinopathy Market Size by Region (2017-2028)
5.2.1 Global Proliferative Diabetic Retinopathy Market Size by Region: 2017-2022
5.2.2 Global Proliferative Diabetic Retinopathy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Proliferative Diabetic Retinopathy Market Size YoY Growth 2017-2028
6.1.2 North America Proliferative Diabetic Retinopathy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Proliferative Diabetic Retinopathy Market Size YoY Growth 2017-2028
6.3.2 Europe Proliferative Diabetic Retinopathy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Proliferative Diabetic Retinopathy Market Size YoY Growth 2017-2028
6.4.2 Latin America Proliferative Diabetic Retinopathy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Proliferative Diabetic Retinopathy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Proliferative Diabetic Retinopathy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Intas Pharmaceuticals
7.1.1 Intas Pharmaceuticals Company Details
7.1.2 Intas Pharmaceuticals Business Overview
7.1.3 Intas Pharmaceuticals Proliferative Diabetic Retinopathy Introduction
7.1.4 Intas Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
7.1.5 Intas Pharmaceuticals Recent Development
7.2 Santen Pharmaceutical
7.2.1 Santen Pharmaceutical Company Details
7.2.2 Santen Pharmaceutical Business Overview
7.2.3 Santen Pharmaceutical Proliferative Diabetic Retinopathy Introduction
7.2.4 Santen Pharmaceutical Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
7.2.5 Santen Pharmaceutical Recent Development
7.3 Bausch Health
7.3.1 Bausch Health Company Details
7.3.2 Bausch Health Business Overview
7.3.3 Bausch Health Proliferative Diabetic Retinopathy Introduction
7.3.4 Bausch Health Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
7.3.5 Bausch Health Recent Development
7.4 Allergan Plc
7.4.1 Allergan Plc Company Details
7.4.2 Allergan Plc Business Overview
7.4.3 Allergan Plc Proliferative Diabetic Retinopathy Introduction
7.4.4 Allergan Plc Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
7.4.5 Allergan Plc Recent Development
7.5 Regeneron Pharmaceuticals
7.5.1 Regeneron Pharmaceuticals Company Details
7.5.2 Regeneron Pharmaceuticals Business Overview
7.5.3 Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Introduction
7.5.4 Regeneron Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
7.5.5 Regeneron Pharmaceuticals Recent Development
7.6 Merck KGaA
7.6.1 Merck KGaA Company Details
7.6.2 Merck KGaA Business Overview
7.6.3 Merck KGaA Proliferative Diabetic Retinopathy Introduction
7.6.4 Merck KGaA Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
7.6.5 Merck KGaA Recent Development
7.7 Cipla
7.7.1 Cipla Company Details
7.7.2 Cipla Business Overview
7.7.3 Cipla Proliferative Diabetic Retinopathy Introduction
7.7.4 Cipla Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
7.7.5 Cipla Recent Development
7.8 Genentech, Inc. (Roche Holdings)
7.8.1 Genentech, Inc. (Roche Holdings) Company Details
7.8.2 Genentech, Inc. (Roche Holdings) Business Overview
7.8.3 Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Introduction
7.8.4 Genentech, Inc. (Roche Holdings) Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
7.8.5 Genentech, Inc. (Roche Holdings) Recent Development
7.9 Novartis
7.9.1 Novartis Company Details
7.9.2 Novartis Business Overview
7.9.3 Novartis Proliferative Diabetic Retinopathy Introduction
7.9.4 Novartis Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
7.9.5 Novartis Recent Development
7.10 Pfizer
7.10.1 Pfizer Company Details
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Proliferative Diabetic Retinopathy Introduction
7.10.4 Pfizer Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
7.10.5 Pfizer Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Proliferative Diabetic Retinopathy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Proliferative Diabetic Retinopathy Market Trends
Table 3. Proliferative Diabetic Retinopathy Market Drivers
Table 4. Proliferative Diabetic Retinopathy Market Challenges
Table 5. Proliferative Diabetic Retinopathy Market Restraints
Table 6. Global Proliferative Diabetic Retinopathy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Proliferative Diabetic Retinopathy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Proliferative Diabetic Retinopathy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Proliferative Diabetic Retinopathy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Proliferative Diabetic Retinopathy Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Proliferative Diabetic Retinopathy Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Proliferative Diabetic Retinopathy Revenue Share by Player, 2017-2022
Table 13. Global Proliferative Diabetic Retinopathy Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Proliferative Diabetic Retinopathy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proliferative Diabetic Retinopathy as of 2021)
Table 15. Top Players of Proliferative Diabetic Retinopathy in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Proliferative Diabetic Retinopathy Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Proliferative Diabetic Retinopathy Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Proliferative Diabetic Retinopathy Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Proliferative Diabetic Retinopathy Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Proliferative Diabetic Retinopathy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Proliferative Diabetic Retinopathy Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Proliferative Diabetic Retinopathy Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Proliferative Diabetic Retinopathy Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Proliferative Diabetic Retinopathy Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Proliferative Diabetic Retinopathy Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Proliferative Diabetic Retinopathy Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Proliferative Diabetic Retinopathy Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Intas Pharmaceuticals Company Details
Table 31. Intas Pharmaceuticals Business Overview
Table 32. Intas Pharmaceuticals Proliferative Diabetic Retinopathy Product
Table 33. Intas Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 34. Intas Pharmaceuticals Recent Development
Table 35. Santen Pharmaceutical Company Details
Table 36. Santen Pharmaceutical Business Overview
Table 37. Santen Pharmaceutical Proliferative Diabetic Retinopathy Product
Table 38. Santen Pharmaceutical Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 39. Santen Pharmaceutical Recent Development
Table 40. Bausch Health Company Details
Table 41. Bausch Health Business Overview
Table 42. Bausch Health Proliferative Diabetic Retinopathy Product
Table 43. Bausch Health Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 44. Bausch Health Recent Development
Table 45. Allergan Plc Company Details
Table 46. Allergan Plc Business Overview
Table 47. Allergan Plc Proliferative Diabetic Retinopathy Product
Table 48. Allergan Plc Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 49. Allergan Plc Recent Development
Table 50. Regeneron Pharmaceuticals Company Details
Table 51. Regeneron Pharmaceuticals Business Overview
Table 52. Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Product
Table 53. Regeneron Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 54. Regeneron Pharmaceuticals Recent Development
Table 55. Merck KGaA Company Details
Table 56. Merck KGaA Business Overview
Table 57. Merck KGaA Proliferative Diabetic Retinopathy Product
Table 58. Merck KGaA Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 59. Merck KGaA Recent Development
Table 60. Cipla Company Details
Table 61. Cipla Business Overview
Table 62. Cipla Proliferative Diabetic Retinopathy Product
Table 63. Cipla Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 64. Cipla Recent Development
Table 65. Genentech, Inc. (Roche Holdings) Company Details
Table 66. Genentech, Inc. (Roche Holdings) Business Overview
Table 67. Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Product
Table 68. Genentech, Inc. (Roche Holdings) Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 69. Genentech, Inc. (Roche Holdings) Recent Development
Table 70. Novartis Company Details
Table 71. Novartis Business Overview
Table 72. Novartis Proliferative Diabetic Retinopathy Product
Table 73. Novartis Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 74. Novartis Recent Development
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Proliferative Diabetic Retinopathy Product
Table 78. Pfizer Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 79. Pfizer Recent Development
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Proliferative Diabetic Retinopathy Product Picture
Figure 2. Global Proliferative Diabetic Retinopathy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Proliferative Diabetic Retinopathy Market Size 2017-2028 (US$ Million)
Figure 4. United States Proliferative Diabetic Retinopathy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Proliferative Diabetic Retinopathy Market Size 2017-2028 (US$ Million)
Figure 6. United States Proliferative Diabetic Retinopathy Market Share in Global 2017-2028
Figure 7. Proliferative Diabetic Retinopathy Report Years Considered
Figure 8. Product Picture of Anti-VEGF Agents
Figure 9. Product Picture of Corticosteroids
Figure 10. Global Proliferative Diabetic Retinopathy Market Share by Type in 2022 & 2028
Figure 11. Global Proliferative Diabetic Retinopathy Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Proliferative Diabetic Retinopathy Market Share by Type (2017-2028)
Figure 13. United States Proliferative Diabetic Retinopathy Market Share by Type in 2022 & 2028
Figure 14. United States Proliferative Diabetic Retinopathy Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Proliferative Diabetic Retinopathy Market Share by Type (2017-2028)
Figure 16. Product Picture of Hospitals
Figure 17. Product Picture of Clinics
Figure 18. Product Picture of Others
Figure 19. Global Proliferative Diabetic Retinopathy Market Share by Application in 2022 & 2028
Figure 20. Global Proliferative Diabetic Retinopathy Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Proliferative Diabetic Retinopathy Market Share by Application (2017-2028)
Figure 22. United States Proliferative Diabetic Retinopathy Market Share by Application in 2022 & 2028
Figure 23. United States Proliferative Diabetic Retinopathy Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Proliferative Diabetic Retinopathy Market Share by Application (2017-2028)
Figure 25. North America Proliferative Diabetic Retinopathy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Proliferative Diabetic Retinopathy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Proliferative Diabetic Retinopathy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. China Taiwan Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Latin America Proliferative Diabetic Retinopathy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 45. Mexico Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Brazil Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Argentina Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Proliferative Diabetic Retinopathy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Turkey Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Saudi Arabia Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. UAE Proliferative Diabetic Retinopathy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Intas Pharmaceuticals Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 53. Santen Pharmaceutical Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 54. Bausch Health Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 55. Allergan Plc Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 56. Regeneron Pharmaceuticals Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 57. Merck KGaA Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 58. Cipla Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 59. Genentech, Inc. (Roche Holdings) Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 60. Novartis Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 61. Pfizer Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Industry Market Size
